Get the Stockscreener App
28.09
1.11%
0.3093
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) Forecast
The First Trust Nasdaq Pharmaceuticals Etf (FTXH) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $27.60, representing a -1.74% decrease from the current price of $28.09. The highest analyst price target is $28.48, and the lowest is $26.73.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FTXH Price Target
Average 26.44
(-5.90% Downside)
Is First Trust Nasdaq Pharmaceuticals Etf (FTXH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.86 | Neutral |
| STOCH(9,6) | 22.74 | Neutral |
| STOCHRSI(14) | 57.16 | Neutral |
| MACD(12,26) | -0.2529 | Sell |
| ADX(14) | 21.72 | Neutral |
| William %R | -49.16 | Neutral |
| CCI(14) | -8.8331 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
27.89
Buy
|
27.85
Buy
|
| MA20 |
28.17
Sell
|
28.06
Buy
|
| MA50 |
28.51
Sell
|
28.33
Sell
|
| MA100 |
28.55
Sell
|
28.28
Sell
|
| MA200 |
27.84
Buy
|
27.83
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, FTXH could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on FTXH, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 48.86 indicates that FTXH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 22.74 indicates that FTXH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 57.16 indicates that FTXH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.72 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -8.8331 indicates that FTXH is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term FTXH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about First Trust Nasdaq Pharmaceuticals Etf financial reports and earnings history, First Trust Nasdaq Pharmaceuticals Etf (FTXH) stock could reach $32.39 by 2030, $46.79 by 2040 and $59.93 by 2050. See the projected annual prices until 2050 of the First Trust Nasdaq Pharmaceuticals Etf stock below:
- First Trust Nasdaq Pharmaceuticals Etf (FTXH) is expected to reach an average price of $38.66 in 2035, with a high prediction of $38.68 and a low estimate of $37.35. This indicates an $37.62% rise from the last recorded price of $28.09.
- First Trust Nasdaq Pharmaceuticals Etf (FTXH) stock is projected to chart a bullish course in 2040, with an average price target of $46.21, representing an $64.48% surge from its current level. The forecast ranges from a conservative $45.79 to a sky-high $46.79.
- Our analysts predict First Trust Nasdaq Pharmaceuticals Etf (FTXH) to jump 86.00% by 2045, soaring from $49.75 to an average price of $52.25, potentially reaching $52.54. While $49.75 is the low estimate, the potential upside is significant.
- First Trust Nasdaq Pharmaceuticals Etf (FTXH) stock is expected to climb by 2050, reaching an average of $59.20, a $110.71% jump from its current level. However, a wide range of estimates exists, with high and low targets of $59.93 and $57.94, respectively, highlighting the market's uncertainty.
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) Year by Year Forecast
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) Price Forecast for 2024
Our forecast for FTXH stock price in 2024 now indicates an average price target of $26.88 with a high forecast of $28.48 and a low forecast of $25.28. The average prediction reflects an decrease of -4.32% from the last recorded price of $28.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $28.19 | $26.73 | $28.48 | +0.35% |
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) Price Forecast for 2025
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) is expected to reach an average price of $26.62 in 2025, with a high prediction of $31.24 and a low estimate of $21.99. This indicates an -5.26% fall from the last recorded price of $28.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $28.78 | $28.30 | $29.53 | +2.46% |
| February, 2025 | $28.61 | $28.53 | $30.15 | +1.86% |
| March, 2025 | $26.36 | $26.12 | $29.85 | -6.16% |
| April, 2025 | $25.01 | $21.99 | $27.75 | -10.96% |
| May, 2025 | $27.88 | $24.29 | $28.13 | -0.77% |
| June, 2025 | $28.24 | $27.24 | $29.93 | +0.51% |
| July, 2025 | $28.50 | $27.10 | $29.77 | +1.45% |
| August, 2025 | $28.75 | $28.02 | $29.16 | +2.34% |
| September, 2025 | $30.22 | $28.76 | $30.79 | +7.57% |
| October, 2025 | $29.74 | $29.36 | $30.79 | +5.88% |
| November, 2025 | $29.94 | $28.87 | $30.88 | +6.59% |
| December, 2025 | $28.89 | $28.81 | $31.24 | +2.83% |
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) Price Forecast for 2026
The predicted value for First Trust Nasdaq Pharmaceuticals Etf (FTXH) in 2026 is set at an average of $31.34. Estimates vary from a peak of $33.16 to a trough of $29.51, indicating an +11.54% surge from the present price of $28.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $31.12 | $29.51 | $32.24 | +10.77% |
| February, 2026 | $31.67 | $30.75 | $32.09 | +12.73% |
| March, 2026 | $32.65 | $30.93 | $32.93 | +16.21% |
| April, 2026 | $32.28 | $31.98 | $33.13 | +14.91% |
| May, 2026 | $32.17 | $30.61 | $32.62 | +14.52% |
| June, 2026 | $31.47 | $30.80 | $32.25 | +12.04% |
| July, 2026 | $32.04 | $31.24 | $32.35 | +14.03% |
| August, 2026 | $32.46 | $31.25 | $32.60 | +15.56% |
| September, 2026 | $32.23 | $31.63 | $32.40 | +14.72% |
| October, 2026 | $32.97 | $31.42 | $33.15 | +17.36% |
| November, 2026 | $32.82 | $32.51 | $33.16 | +16.82% |
| December, 2026 | $31.93 | $31.25 | $32.85 | +13.66% |
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for First Trust Nasdaq Pharmaceuticals Etf (FTXH) is $32.46, with a high forecast of $34.74 and a low forecast of $30.18. This indicates an +15.54% increase from the last price of $28.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $32.06 | $31.55 | $32.29 | +14.13% |
| February, 2027 | $32.67 | $31.74 | $33.46 | +16.30% |
| March, 2027 | $32.81 | $31.43 | $32.98 | +16.79% |
| April, 2027 | $31.97 | $31.97 | $33.59 | +13.82% |
| May, 2027 | $31.99 | $30.98 | $32.36 | +13.89% |
| June, 2027 | $31.57 | $30.18 | $32.41 | +12.37% |
| July, 2027 | $33.24 | $31.53 | $33.28 | +18.31% |
| August, 2027 | $32.48 | $32.48 | $34.74 | +15.63% |
| September, 2027 | $32.90 | $31.61 | $33.32 | +17.12% |
| October, 2027 | $33.28 | $30.83 | $33.28 | +18.47% |
| November, 2027 | $33.05 | $32.52 | $33.64 | +17.65% |
| December, 2027 | $33.01 | $32.47 | $33.41 | +17.52% |
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) Price Forecast for 2028
In 2028, First Trust Nasdaq Pharmaceuticals Etf (FTXH) is projected to reach an average price of $32.71, with a high projection of $35.11 and a low estimate of $30.30. This indicates an +16.42% rise from the last price of $28.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $31.97 | $31.13 | $32.99 | +13.82% |
| February, 2028 | $30.58 | $30.30 | $32.42 | +8.87% |
| March, 2028 | $32.91 | $30.44 | $33.34 | +17.16% |
| April, 2028 | $34.51 | $32.85 | $34.57 | +22.84% |
| May, 2028 | $33.93 | $33.67 | $34.93 | +20.79% |
| June, 2028 | $34.15 | $33.82 | $35.11 | +21.58% |
| July, 2028 | $33.95 | $33.44 | $34.22 | +20.84% |
| August, 2028 | $31.82 | $31.23 | $33.85 | +13.28% |
| September, 2028 | $33.48 | $31.61 | $33.74 | +19.19% |
| October, 2028 | $33.11 | $32.60 | $33.66 | +17.86% |
| November, 2028 | $32.66 | $31.97 | $33.23 | +16.27% |
| December, 2028 | $32.17 | $32.17 | $33.37 | +14.51% |
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) Price Forecast for 2029
The 2029 price forecast for First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) is $32.92 on average, with a high prediction of $35.25 and a low estimate of $30.60. This represents an +17.20% increase from the previous price of $28.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $32.82 | $32.21 | $33.52 | +16.84% |
| February, 2029 | $33.56 | $32.87 | $33.94 | +19.47% |
| March, 2029 | $32.52 | $32.52 | $33.85 | +15.76% |
| April, 2029 | $31.76 | $31.69 | $32.68 | +13.06% |
| May, 2029 | $31.26 | $30.60 | $31.74 | +11.26% |
| June, 2029 | $32.11 | $31.13 | $32.23 | +14.32% |
| July, 2029 | $34.10 | $32.20 | $34.16 | +21.40% |
| August, 2029 | $33.95 | $33.51 | $34.37 | +20.86% |
| September, 2029 | $34.57 | $33.87 | $35.25 | +23.05% |
| October, 2029 | $34.87 | $34.24 | $35.00 | +24.13% |
| November, 2029 | $32.79 | $32.61 | $34.82 | +16.74% |
| December, 2029 | $31.76 | $31.27 | $33.47 | +13.05% |
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) Price Forecast for 2030
First Trust Nasdaq Pharmaceuticals Etf Stock (FTXH) is expected to reach an average price of $31.76 in 2030, with a high forecast of $35.82 and a low forecast of $27.71. This signifies an +13.06% surge from the last price of $28.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $32.15 | $30.77 | $32.39 | +14.44% |
| February, 2030 | $31.72 | $31.64 | $32.74 | +12.92% |
| March, 2030 | $31.62 | $31.08 | $31.84 | +12.54% |
| April, 2030 | $31.62 | $31.11 | $31.70 | +12.54% |
| May, 2030 | $31.44 | $30.86 | $31.99 | +11.93% |
| June, 2030 | $32.29 | $31.03 | $32.48 | +14.95% |
| July, 2030 | $34.05 | $32.15 | $34.05 | +21.21% |
| August, 2030 | $34.89 | $33.74 | $35.18 | +24.19% |
| September, 2030 | $35.52 | $34.38 | $35.81 | +26.43% |
| October, 2030 | $34.75 | $34.20 | $35.82 | +23.69% |
| November, 2030 | $28.62 | $27.94 | $34.59 | +1.86% |
| December, 2030 | $32.24 | $27.71 | $32.56 | +14.75% |
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):